Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival

Hani Levkovitch-Verbin1, Rima Dardik, Shelly Vander

  • 1Sam Rothberg Ophthalmic Molecular Biology Laboratory, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. hani.verbin@sheba.health.gov.il

Abstract

Insights

Gene expression changes in the retina were studied in response to elevated intraocular pressure (IOP) and optic nerve transection (ONT). Proapoptotic and prosurvival genes were upregulated, with glaucoma showing sustained changes long after IOP normalization.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Neuroscience

Background:

  • Elevated intraocular pressure (IOP) and optic nerve transection (ONT) are key factors in glaucoma pathogenesis.
  • Understanding the molecular mechanisms, particularly gene expression changes, is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate temporal gene expression alterations in the retina following experimental glaucoma and ONT.
  • To identify specific genes and signaling pathways involved in retinal response to these insults.

Main Methods:

  • Gene array analysis of 18 signal transduction pathways in rat retinas post-ONT.
  • Validation of upregulated genes (Ei24, Gadd45a, IAP-1, Cdk2) using quantitative RT-PCR.
  • Assessment of protein levels via Western blot and immunohistochemistry in experimental glaucoma and ONT models.

Main Results:

  • Early, simultaneous upregulation of proapoptotic genes (Ei24, Gadd45a) and prosurvival gene (IAP-1) after ONT, returning to baseline within 2 weeks.
  • In experimental glaucoma, Gadd45a showed sustained upregulation for 2 months, even after IOP normalized, while IAP-1 returned to baseline earlier.
  • Ei24 and Cdk2 showed minimal upregulation in glaucoma; Gadd45a and IAP-1 proteins were upregulated in the retinal ganglion cell layer.

Conclusions:

  • The p53 signaling pathway is significantly implicated in both glaucoma and ONT.
  • Upregulation of IAP-1 suggests an endogenous neuroprotective response.
  • Glaucoma-induced gene expression changes are gradual and persist long after intraocular pressure normalizes, highlighting the chronic nature of the disease.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...